CNBC's Julia Boorstin joins 'Money Movers' to discuss Netflix leaning into live events.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Organon & Co. (NYSE: OGN) in the United States District Court for the District of New Jersey. Investors who acquired Organon shares during the class period are encouraged to contact the law firm before the lead plaintiff motion deadline on July 22, 2025.

e.l.f. Beauty's recent Rhode acquisition increases debt and risk, especially as net sales growth slowed to just 4% last quarter. The deal may not align with ELF's core low-price segment, raising concerns about product fit and long-term brand synergy. Heavy reliance on China for production and lack of FY26 guidance add significant uncertainty to the outlook.

TESL, NITE, XLY, VCR and FDIS can help investors tap Tesla's robotaxi momentum and Musk's renewed focus on AI and business after political exit.

Google and the Department of Justice are set to present their closing arguments Friday (May 30) in an antitrust case that could force the tech giant to sell its Chrome browser, stop paying Apple to be its default search engine and share data with competitors.

Ray Wang, Constellation Research principal analyst and founder, joins 'Money Movers' to discuss Apple, Alphabet and the outlook for the other 'Mag 7' stocks.

AEO posts disappointing Q1 results, and warns of continued pressure in Q2 as tariffs, weak demand and margin erosion are likely to weigh on performance.

Between GTA VI's delay, massive share dilution, deteriorating financial metrics, and over-reliance on declining revenue streams, TTWO faces multiple headwinds.

This is good news in terms of demonstrating economic strength, though not for those who'd like to see the Fed lower interest rates.

CRWD's high valuation, customer challenges and competitive headwinds suggest that it is wise to avoid the stock ahead of its first-quarter fiscal 2026 results.

SCHD offers a compelling combination of low fees, high dividend yield, and attractive valuation compared to broader market ETFs like SPY. The ETF is concentrated in value and defensive sectors, making it less diversified but more resilient and income-focused than peers such as VYM and DGRO. Despite lagging in recent total returns, SCHD's lower drawdown and higher yield make it appealing for conservative, income-oriented investors.

Li Auto delivered strong Q1 results, beating earnings and revenue estimates, with impressive delivery growth and industry-leading vehicle margins. I believe Li Auto is the most attractive EV start-up due to its solid profitability, superior margins, and undervalued share price. Despite risks from slowing growth and pricing pressure, Li Auto's low valuation and profitability offer downside protection for long-term investors.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Ascendiant Capital Markets LLC (“Ascendiant”) publishes equity research coverage on Society Pass Inc. (Nasdaq: SOPA) (“SoPa” or the “Company”), Southeast Asia's (SEA) next generation, data-driven, loyalty, fintech and e-commerce ecosystem.

HubSpot stock slides after Alphabet drops buyout plan, but rising earnings estimates and AI-driven growth may help HUBS regain traction.

ATI signs a multi-year deal with Airbus for titanium products supply, boosting aerospace and defense leadership.

LI Q1 earnings fall year over year, while revenues rise due to a 15.5% year-over-year increase in vehicle deliveries.

Dell Technologies' first-quarter fiscal 2026 results reflect strong AI-driven growth and an expanding backlog.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151017&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151016&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151018&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.